ABOUT US
TECHNOLOGY
BUSINESS
R&D
IR
PR
RECRUIT
ENG
KOR
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
CI
Code of Ethics
TECHNOLOGY
Core Technology
Multi-Omics
Microbiome
Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
PMAS
MBR
Multi-Omics Research
NGS
Analysis of Metabolome
Management of Microbial Resource
Research on Development of New Drugs
A microbiome healthcare company
serving the value of healthy life
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
CI
Code of Ethics
TECHNOLOGY
Core Technology
PMAS
MBR
Multi-Omics
Multi-Omics Research
Microbiome
NGS
Metabolome
Analysis of Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDMO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Management of Microbial Resource
Research on Development of New Drugs
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
A microbiome healthcare company
serving the value of healthy life
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
CI
Code of Ethics
TECHNOLOGY
Core Technology
PMAS
MBR
Multi-Omics
Multi-Omics Research
Microbiome
NGS
Metabolome
Analysis of Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDMO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Management of Microbial Resource
Research on Development of New Drugs
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
PR
PR
ABOUT US
TECHNOLOGY
BUSINESS
R&D
IR
PR
RECRUIT
Media
Notice
Media
Media
“The Key to Getting the Most Out of Supplements Lies in Gut Health: The Secret B..
2026.10.27
HEM Pharma Expands Its Microbiome Business with a Focus on Commercialization
2026.09.10
HEM Pharma Conducts Real-World Validation of AI-Powered Health Management Soluti..
2026.09.09
HEM Pharma Launches Probiotics with Amway, From R&D to Finished Product Supply
2026.09.02
HEM Pharma’s Q2 Revenue Jumps 45.5%, Driven by Growth in Japan’s Analysis Servic..
2026.08.25
HEM Pharma Secures KRW 54B Investment for Second Sejong Plant
2026.08.18
The Microbiome: The Foundation of Whole-Body Health, Highlighted by Bill Gates
2026.08.03
HEM Pharma and Celltrion Launch BiGNAL™ AI Health Management Pilot
2026.08.03
HEM Pharma and Amway Japan Host “One & Only Microbiome Lab”
2026.07.08
HEM Pharma Participates in IPC 2026, Expanding Global Collaboration in Microbiom..
2026.07.08
HEM Pharma Reinforces Executive Team with Former Eugene Investment & Securities ..
2026.07.08
HEM Pharma CEO Joseph Ji: "Integrated Data, Manufacturing, and Commercializ..
2026.06.29
1
2
3
4
5